The L1 cell adhesion molecule (L1CAM; CD171) has been reported as a poor prognostic marker in various solid tumors, including EC [22,23,24,25], colorectal cancer [26], gastric cancer [27,28], ovarian cancer [29], and breast cancer [30]. Here, L1CAM is linked to ovarian carcinoma.